As of Feb 23
| +0.55 / +5.39%|
The 3 analysts offering 12-month price forecasts for Avadel Pharmaceuticals PLC have a median target of 17.00, with a high estimate of 25.00 and a low estimate of 16.00. The median estimate represents a +57.99% increase from the last price of 10.76.
The current consensus among 4 polled investment analysts is to Buy stock in Avadel Pharmaceuticals PLC. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.